Adult onset immunodeficiency disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 AOID cases enrolled in a previous study 30 cases 2 Adult patients who will have anti-IFN-gamma autoantibodies measured at the Department of Respiratory Medicine, Kumamoto University after the approval of this study in 2024 30 cases per year Patients who fall under 1 or 2 must be able to visit the hospital once every 12 months in conjunction with their medical treatment. 3 Cases in which the patient's consent is obtained in writing.
Exclusion criteria
Exclusion criteria: (1) Cases under 18 years of age (2) Other cases deemed inappropriate by the physician in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Establish a registry and specimen repository of AOID cases in Japan 2) Creation of a database of information on cases at the time of diagnosis and their progress. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Changes in disease status after diagnosis 2) Changes in antibody titer after diagnosis | — |
Countries
Japan
Contacts
Kumamoto University Graduate School of Life Sciences Respiratory Medicine